Overview

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the patient acceptance of a new PEG3350 dose formulation in children currently treated with PEG3350 powder for treatment of constipation.
Phase:
Phase 4
Details
Lead Sponsor:
Braintree Laboratories
Treatments:
Polyethylene glycol 3350